[1]李 芳,冉向阳,李 玮,等.缺血性脑卒中患者血清GR,SOD,Cys-C,Hcy和Lp(a)水平对预后的预警价值研究[J].现代检验医学杂志,2025,40(02):92.[doi:10.3969/j.issn.1671-7414.2025.02.017]
 LI Fang,RAN Xiangyang,LI Wei,et al.Study on the Prognostic Warning Value of Serum GR, SOD, Cys-C, Hcy and Lp(a) Levels in Patients with Cerebral Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2025,40(02):92.[doi:10.3969/j.issn.1671-7414.2025.02.017]
点击复制

缺血性脑卒中患者血清GR,SOD,Cys-C,Hcy和Lp(a)水平对预后的预警价值研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第40卷
期数:
2025年02期
页码:
92
栏目:
论著
出版日期:
2025-03-15

文章信息/Info

Title:
Study on the Prognostic Warning Value of Serum GR, SOD, Cys-C, Hcy and Lp(a) Levels in Patients with Cerebral Ischemic Stroke
文章编号:
1671-7414(2025)02-092-07
作者:
李 芳1冉向阳1李 玮1史文俊1安黎云1康 林2
(1. 联勤保障部队第九八〇医院检验科,石家庄 050000;2. 河北省人民医院检验科,石家庄 050000)
Author(s):
LI Fang1RAN Xiangyang1LI Wei1SHI Wenjun1AN Liyun1KANG Lin2
(1. Department of Clinical Laboratory,980 Hospital of Joint Logistic Support Force,Shijiazhuang 050000, China;2. Department of Clinical Laboratory,Hebei Provincial People’s Hospital,Shijiazhuang 050000, China)
关键词:
缺血性脑卒中谷胱甘肽还原酶超氧化物歧化酶胱抑素C同型半胱氨酸脂蛋白a
分类号:
R743.3;R446.112
DOI:
10.3969/j.issn.1671-7414.2025.02.017
文献标志码:
A
摘要:
(1. 联勤保障部队第九八〇医院检验科,石家庄 050000;2. 河北省人民医院检验科,石家庄 050000)
Abstract:
Objective To explore the prognostic value of serum glutathione reductase (GR),superoxide dismutase (SOD), cystatin C (Cys-C),homocysteine (Hcy) and lipoprotein a [Lp(a)] levels in patients with cerebral ischemic stroke(CIS),and to provide a reference for improving the prognosis of CIS patients. Methods 126 patients with CIS admitted to the 980th Hospital of Joint Logistics Support Force from June 2022 to April 2023 were selected as the observation group,another 126 healthy individuals were selected as the control group at a ratio of 1:1. The expression levels of GR, SOD, Cys-C,Hcy and Lp(a) in the two groups were detected and compared after admission and during physical examination. The degree of neurological deficit in patients with CIS was classified into mild (NIHSS:2 ~ 4 points,n=35), moderate (NIHSS:5 ~ 15 points,n=47), moderate-severe (NIHSS:16 ~ 20 points,n=26) and severe (NIHSS:21 ~ 42 points,n=18) according to the National Institutes of Health Stroke Scale (NIHSS). The expression of serum GR, SOD, Cys-C, Hcy and Lp(a) in patients with different degrees of neurological deficit was compared, and the correlation between each indicator and the degree of neurological deficit was analyzed. The observation group received intravenous thrombolytic therapy after admission and was reexamined one day after thrombolysis. After treatment, follow-up visits were conducted for 28 days. According to the patient’s condition (modified Rankin scale), patients were divided into good prognosis (n=94)and poor prognosis groups(n=32). The levels of each indicator in patients with different prognoses were compared, and the predictive value of GR, SOD, Cys-C, Hcy and Lp(a) expression for poor prognosis and early warning were analyzed. Results The expression levels of serum GR (48.54±3.07U/L)and SOD(157.17±25.47U/ml)in the observation group were lower than those in the control group (61.68±3.15U/L,203.63±18.31U/ml), while the expression levels of Cys-C(1.24±0.28mg/L), Hcy(15.21±1.62μmol/ L)and Lp(a)(386.53±52.16mg/L)were higher than those in the control group(0.82±0.23mg/L,9.58±0.60μmol/L, 257.83±45.34mg/L), with statistically significant differences (t=13.011 ~ 36.582,all P<0.05). As the disease progressed, the expression levels of GR and SOD gradually decreased, while the expression levels of Cys-C, Hcy and Lp(a) gradually increased, with statistically significant differences (F=14.685 ~ 197.041,all P<0.05). Spearman analysis,GR and SOD were negatively correlated with the degree of neurological deficit in patients with CIS (r=-0.814, -0.753, all P<0.05), while Cys-C, Hcy and Lp(a) were positively correlated with the degree of neurological deficit in patients with CIS (r=0.647, 0.782, 0.724, all P<0.05). The expression of GR and SOD in patients with good prognosis at admission and 1 day after thrombolysis was higher than that in patients with poor prognosis (t = 9.109,6.338;2.934,4.358,all P < 0.05), while the expression of Cys-C, Hcy and Lp(a) was lower than that in patients with poor prognosis (t = 5.246,5.118,8.561;4.636,5.298,7.461,all P < 0.05). The AUC(95%CI) of combined prediction of GR, SOD, Cys-C, Hcy and Lp(a) at admission was 0.898 (0.832 ~ 0.945), and the AUC(95%CI) of combined prediction of GR, SOD, Cys-C, Hcy and Lp(a) at 1 day after thrombolysis was 0.931 (0.871 ~ 0.968). The RR (95%CI)values caused by the expression of GR, SOD, Cys-C, Hcy and Lp(a) at 1 day after thrombolysis were 2.868 (1.594 ~ 5.161), 3.194 (1.807 ~ 5.645), 0.155 (0.082 ~ 0.291), 0.150 (0.071 ~ 0.319) and 0.227(0.119 ~ 0.435). Conclusion Abnormal changes in the levels of GR, SOD, Cys-C, Hcy and Lp(a) are closely related to the degree of neurological deficit and prognosis in patients with CIS. Early combined detection of GR, SOD, Cys-C, Hcy and Lp(a) levels has high predictive value and early warning for evaluating the poor prognosis of patients with CIS.

参考文献/References:

[1] CANDELARIO-JALIL E, DIJKHUIZEN R M, MAGNUS T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities [J]. Stroke, 2022, 53(5): 1473-1486.
[2] SAVUSHKINA O K , TERESHKINA E B , PROKHOROVA T A, et al. Platelet glutathione reductase and glutathione-S-transferase in elderly patients with depression [J]. Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova, 2021, 121(9): 79-84.
[3] YANG Xitong, YANG Sulian, XU Hongyang, et al. Superoxide dismutase gene polymorphism is associated with ischemic stroke risk in the China Dali region Han population[J]. Neurologist, 2021, 26(2): 27-31.
[4] 侯越, 赵妍, 王友明, 等. 脑卒中患者血清胱抑素C水平与卒中后认知障碍相关性的Meta 分析[J]. 现代检验医学杂志,2022,37(2):142-147. HOU Yue, ZHAO Yan, WANG Youming, et al. Meta analysis of the correlation between cystatin C level in stroke patientis and post stroke cognitive impairment[J]. Journal of Modern Laboratory Medicine, 2022, 37(2): 142-147.
[5] 朱芳萱, 卢锋, 李卫, 等. 联合检测同型半胱氨酸与脂蛋白a 对高血压患者动脉粥样硬化的预测意义[J].国际心血管病杂志,2023,50(5):322-325. ZHU Fangxuan, LU Feng, LI Wei, et al. Combined test for the predictive significance of homocysteine and lipoprotein (a) for atherosclerosis in hypertensive patients[J]. International Journal of Cardiovascular Disease, 2023, 50(5): 322-325.
[6] 中华医学会神经病学分会. 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682. Chinese Society of Neurology,Chinese Stroke Society, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018 [J].Chinese Journal of Neurology, 2018, 51(9): 666-682.
[7] FAN Juilin, BRASSARD P, RICKARDS C A, et al. Integrative cerebral blood flow regulation in ischemic stroke[J]. Journal of Cerebral Blood Flow and Metabolism, 2022, 42(3): 387-403.
[8] MASTRANGELO M, GIORDO L, RICCIARDI G, et al. Acute ischemic stroke in childhood: a comprehensive review[J].European Journal of Pediatrics, 2022, 181(1): 45-58.
[9] 郭继勃, 钟曌, 郭昊, 等. 急性缺血性脑卒中患者血浆LIPCAR 和MMP-9 水平与病情严重程度及溶栓治疗后认知功能的关系研究[J]. 现代检验医学杂志,2023,38(5):40-46. GUO Jibo, ZHONG Zhao, GUO Hao, et al. Study on the relationship between peripheral blood LIPCAR, MMP-9 and severity of acute ischemic stroke and cognitive function after RT-PA intravenous thrombolysis[J]. Journal of Modern Laboratory Medicine, 2023, 38(5): 40-46.
[10] GUAN Ya, NIU Hong, LIU Zhongting, et al. Sustained oxygenation accelerates diabetic wound healing by promoting epithelialization and angiogenesis and decreasing inflammation[J]. Science Advances, 2021, 7(35): eabj0153.
[11] LIMA A C, REIS R L, FERREIRA H, et al. Glutathione reductase-sensitive polymeric micelles for controlled drug delivery on arthritic diseases [J]. ACS Biomaterials Science & Engineering, 2021, 7(7): 3229-3241.
[12] 李淑丽, 陆善词, 王军, 等. 血清谷胱甘肽还原酶活性水平评估乙型肝炎肝损伤患者的临床价值[J]. 国际检验医学杂志,2020,41(15):1844-1848. LI Shuli, LU Shanci, WANG Jun, et al. The clinical value of serum glutathione reductase activity in the evaluation of hepatitis B patients with liver injury[J]. International Journal of Laboratory Medicine, 2020, 41(15): 1844-1848.
[13] BUSHUEVA O, BARYSHEVA E, MARKOV A, et al. DNA hypomethylation of the MPO gene in peripheral blood leukocytes is associated with cerebral stroke in the acute phase[J]. Journal of Molecular Neuroscience, 2021, 71(9): 1914-1932.
[14] 沈利洪, 邵丽佳, 王利民. 缺血性脑卒中患者血清谷胱甘肽还原酶活性及同型半胱氨酸水平的变化及临床意义[J]. 浙江医学,2021,43(19):2096-2099. SHEN Lihong, SHAO Lijia, WANG Limin. Glutathione reductase activity and homocysteine levels in patients with ischemic stroke and their clinical significance[J].Zhejiang Medical Journal, 2021, 43(19): 2096-2099.
[15] CHEN Lei, MA Shanbo, SHI Min, et al. A new nitronyl nitroxide radical with salicylic acid framework attenuates blood-brain barrier disruption and oxidative stress in a rat model of middle cerebral artery occlusion[J]. Neuroreport, 2022, 33(3): 129-136.
[16] SAXENA P, SELVARAJ K, KHARE S K, et al. Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases[J].Biotechnology Letters, 2022, 44(1): 1-22.
[17] 满春露, 杨青松. 血清脂蛋白相关磷脂酶A2 和超氧化物歧化酶在脑小血管病患者轻度认知障碍中的临床价值[J]. 检验医学,2022,37(10):939-943. MAN Chunlu, YANG Qingsong. Clinical value of serum lipoprotein-related phospholipase A2 combined with superoxide dismutase in predicting mild cognitive impairment in cerebral small vessel disease patients[J].Laboratory Medicine, 2022, 37(10): 939-943.
[18] LIN Shaopeng, TU Chuanmeizi, HUANG Wenyao, et al.in ischemic stroke patients[J]. Stroke and Vascular Neurology, 2022, 7(2): 124-131.
[9] AMANO Y, SANO H, FUJIMOTO A, et al. Cortical and internal watershed infarcts might be key signs for predicting neurological deterioration in patients with internal carotid artery occlusion with mild symptoms[J].Cerebrovascular Diseases Extra, 2020, 10(2): 76-83.
[10] 李君朝,申志国,纪朋曼,等.急性脑梗死患者血清FGL2 和TSPO 表达水平及其与神经功能缺损程度和预后的相关性研究[J].现代检验医学杂志,2023,38(3):138-142. LI Junchao, SHEN Zhiguo, JI Pengman, et al. Expression levels of serum FGL2 and TSPO in patients with acute cerebral infarction and their correlation with the degree of neurological impairment and prognosis [J]. Journal of Modern Laboratory Medicine, 2023, 38(3): 138-142.
[11] HO Chaikang, ZHENG Danning, SUN Jiaming, et al. LRG-1 promotes fat graft survival through the RAB31-mediated inhibition of hypoxia-induced apoptosis[J]. Journal of Cellular and Molecular Medicine, 2022, 26(11): 3153-3168.
[12] MORITSUBO M, FURUTA T, MIYOSHI J, et al. Increased expression of leucine-rich α-2 glycoprotein 1 as a predictive biomarker of favorable progression-free survival in meningioma[J]. Neuropathology, 2024, 44(2): 96-103.
[13] PARK H N, SONG Minji, CHOI Y E, et al. LRG1 promotes ECM integrity by activating the TGF-β signaling pathway in fibroblasts[J]. International Journal of Molecular Sciences, 2023, 24(15): 12445.
[14] 张萌, 潘旭东, 马爱军. 富亮氨酸ɑ2- 糖蛋白-1 调节转化生长因子-β 信号通路在缺血性卒中中的作用[J]. 国际脑血管病杂志,2021,29(1):53-57. ZHANG Meng, PAN Xudong, MA Aijun. Effect of leucinerichα2-glycoprotein-1 on ischemic stroke by regulating transforming growth factorβsignaling pathway [J]. International Journal of Cerebrovascular Diseases, 2021, 29(1): 53-57.
[15] 吕志坤, 魏萌萌, 李国珍, 等. 头颈部CTA 联合动态动脉硬化指数在急性分水岭脑梗死中的诊断及预后价值分析[J]. 中国动脉硬化杂志,2022,30(11):966-973, 1012. L? Zhikun, WEI Mengmeng, LI Guozhen, et al. Study on the diagnostic and prognostic value of head and neck CTA combined with ambulatory arterial stiffness index in acute cerebral watershed infarction [J]. Chinese Journal of Arteriosclerosis, 2022, 30(11): 966-973, 1012.
[16] 李海英, 魏烁瑾, 王怀立, 等. 亮氨酸的α-2- 糖蛋白-1?可溶性白细胞分化抗原14 亚型及降钙素原在细菌性脑膜炎及病毒性脑炎诊治中的作用[J]. 中国临床医生杂志,2022,50(6):724-727. LI Haiying, WEI Shuojin, WANG Huaili, et al.The role of α-2-glycoprotein-1, soluble leukocyte differentiation antigen 14 subtype and procalcitonin in the diagnosis and treatment of bacterial meningitis and viral encephalitis [J].Chinese Journal for Clinicians,2022, 50(6): 724-727.
[17] IWANAGA T, NIO-KOBAYASHI J.Cellular expression of CD26/dipeptidyl peptidase IV[J]. Biomedical Research, 2021, 42(6): 229-237.
[18] 孙静,石丽媛,康美丽.血清二肽基肽酶4 水平与冠状动脉支架内再狭窄的相关性分析[J].安徽医药,2023,27(11):2190-2193. SUN Jing, SHI Liyuan, KANG Meili. Correlation analysis between serum DPP4 level and coronary instent restenosis[J]. Anhui Medical and Pharmaceutical Journal, 2023, 27(11): 2190-2193.
[19] WANG Yixuan,HU Hao,LIU Xinyu, et al. Hypoglycemic medicines in the treatment of Alzheimer’s disease: pathophysiological links between AD and glucose metabolism [J]. Frontiers in Pharmacology, 2023, 14: 1138499.
[20] LI Luxin, LIAN Xu, WANG Zhilong, et al. The dipeptidyl peptidase-4 inhibitor sitagliptin ameliorates renal injury in type 1 diabetic mice via inhibiting the TGF-β/Smad signal pathway[J]. Pharmazie, 2019, 74(4): 239-242.

相似文献/References:

[1]马 炜,朱 俊,徐 健,等.NLR与缺血性脑卒中患者预后关系研究[J].现代检验医学杂志,2016,31(04):139.[doi:10.3969/j.issn.1671-7414.2016.04.043]
 MA Wei,ZHU Jun,XU Jian,et al.Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis for Acute Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2016,31(02):139.[doi:10.3969/j.issn.1671-7414.2016.04.043]
[2]邓 凯,许 薇,李 燕.缺血性脑卒中患者血浆vWF:Ag和S100B检测的临床意义[J].现代检验医学杂志,2017,32(05):52.[doi:10.3969/j.issn.1671-7414.2017.05.014]
 DENG Kai,XU Wei,LI Yan.Clinical Application of Detection of Plasma vWF:Ag and S100B in Ischemic Cerebral Apoplexy Disease[J].Journal of Modern Laboratory Medicine,2017,32(02):52.[doi:10.3969/j.issn.1671-7414.2017.05.014]
[3]张 艳a,刘 翔a,李鸿钏a,等.血清脂蛋白磷脂酶A2 和血浆抗凝血酶Ⅲ对2 型糖尿病患者发生缺血性脑卒中风险的评估价值[J].现代检验医学杂志,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
 ZHANG Yana,LIU Xianga,LI Hong-chuana,et al.Evaluation Value of Serum Lipoprotein-Associated Phospholipase A2 and Plasma Antithrombin Ⅲ on the Risk of Ischemic Stroke in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(02):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
[4]利荣乔.血清Galectin-3和HDL-C水平检测对急性缺血性脑卒中预后的影响研究[J].现代检验医学杂志,2021,36(05):128.[doi:10.3969/j.issn.1671-7414.2021.05.029]
 LI Rong-qiao.Effect of Serum Galectin-3 and HDL-C Levels on Prognosis of AcuteIschemic Stroke[J].Journal of Modern Laboratory Medicine,2021,36(02):128.[doi:10.3969/j.issn.1671-7414.2021.05.029]
[5]杜龙庭,勿坡巫且,许春梅,等.缺血性脑卒中患者血清miR-155和PDCD4mRNA表达水平与颈动脉支架成形术后再狭窄的相关性研究[J].现代检验医学杂志,2022,37(02):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]
 DU Long-ting,WUPO Wu-qie,XU Chun-mei,et al.Correlation between the Expression of miR-155, PDCD4 mRNA and Restenosis after Carotid Artery Stenting in Patients with Cerebral Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2022,37(02):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]
[6]何 涛a,孔德强a,韩雪飞a,等.缺血性脑卒中患者行颈动脉支架成形术前血清CCR5,SDF-1 mRNA 表达水平与术后支架内再狭窄的相关性研究[J].现代检验医学杂志,2022,37(06):171.[doi:10.3969/j.issn.1671-7414.2022.06.033]
 HE Taoa,KONG De-qianga,HAN Xue-feia,et al.Correlation between Serum CCR5, SDF-1 mRNA Expression Levels and Postoperative In-stent Restenosis in Patients with Ischemic Stroke before Carotid Artery Stenting[J].Journal of Modern Laboratory Medicine,2022,37(02):171.[doi:10.3969/j.issn.1671-7414.2022.06.033]
[7]王桂瑜,欧阳葵,苏小田,等.缺血性脑卒中患者血清LncRNA MEG8 表达水平及临床价值研究[J].现代检验医学杂志,2023,38(04):105.[doi:10.3969/j.issn.1671-7414.2023.04.019]
 WANG Guiyu,OUYANG Kui,SU Xiaotian,et al.Expression Level of Serum LncRNA MEG8 and Its Clinical Significance in Patients with Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2023,38(02):105.[doi:10.3969/j.issn.1671-7414.2023.04.019]
[8]高继英a,石代乐b,王 刚c.缺血性脑卒中患者血清LncRNA SNHG8 的表达及临床意义[J].现代检验医学杂志,2023,38(05):75.[doi:10.3969/j.issn.1671-7414.2023.05.014]
 GAO Jiyinga,SHI Daileb,WANG Gangc.Expression and Clinical Significance of Serum LncRNA SNHG8 in Patients with Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2023,38(02):75.[doi:10.3969/j.issn.1671-7414.2023.05.014]

备注/Memo

备注/Memo:
基金项目:2021 年度河北省医学科学研究课题计划:20210268。
作者简介:李芳(1983-),女,本科,主管技师,研究方向:生化检验。
通讯作者:安黎云(1971-),女,本科,副主任技师,研究方向:免疫学,E-mail:hyla7649@21cn.com。
更新日期/Last Update: 2025-03-15